Pharma Stability: Insights, Guidelines, and Expertise
Biologic molecules—such as monoclonal antibodies, peptides, and fusion proteins—are inherently unstable due to their complex structure. During formulation development, they are exposed to varying pH levels, ionic strengths, surfactants, and containers. Each component and condition can affect:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Biologic drugs are sensitive to environmental, equipment, and procedural changes. Even slight variations during transfer can impact:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Biologics are sensitive to subtle environmental and formulation changes that may cause:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Stability studies ensure that a CGT product maintains its identity, purity, potency, and safety from the point of manufacture to the point of administration. These studies help determine:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.